Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen–positive liver transplant recipients after longterm minimal immunosuppression

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-6473|22|9|1205-1213

ISSN： 1527-6465

Source： LIVER TRANSPLANTATION, Vol.22, Iss.9, 2016-09, pp. : 1205-1213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of hepatitis B virus transmission and antiviral therapy among hepatitis B surface antigen‐positive pregnant women

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 12, 2015-12 ,pp. : 1870-1876

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 1398-2273, Iss. 5, 2015-10 ,pp. : 695-701

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 5, 2015-10 ,pp. : 695-701

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of hepatitis B virus subgenotype on antiviral response in nucleoside‐treated hepatitis B envelope antigen‐positive patients

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 2, 2018-02 ,pp. : 134-143

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevention of Hepatitis B Virus Reinfection in Liver Transplant Recipients

By  

Intervirology, Vol. 57, Iss. 3-4, 2014-07 ,pp. : 196-201

Karger

Access to resources Recommend Favorite